Bristol Myers Squibb announced topline results from the pivotal phase 3 ALOFT─IPF trial evaluating the efficacy, safety and tolerability of admilparant...
Intensity Therapeutics Competitors or Alternatives
Intensity Therapeutics's top competitors include Amgen, AstraZeneca and Bristol-Myers Squibb.
Intensity Therapeutics VS Amgen
Amgen is perceived as one of Intensity Therapeutics's biggest rivals. Amgen is headquartered in Thousand Oaks, California, and was founded in 1980. Like Intensity Therapeutics, Amgen also operates in the Pharmaceuticals & Biotechnology industry. Amgen generates ∞% the revenue of Intensity Therapeutics.
Intensity Therapeutics VS AstraZeneca
AstraZeneca is one of Intensity Therapeutics's top competitors. AstraZeneca is a Public company that was founded in 1999 in Cambridge, England. Like Intensity Therapeutics, AstraZeneca also operates in the Biotechnology field. Compared to Intensity Therapeutics, AstraZeneca has 94,298 more employees.
Intensity Therapeutics VS Bristol-Myers Squibb
Bristol-Myers Squibb has been one of Intensity Therapeutics's top competitors. Bristol-Myers Squibb was founded in 1858 in Princeton, New Jersey. Like Intensity Therapeutics, Bristol-Myers Squibb also works within the Pharmaceuticals & Biotechnology field. Bristol-Myers Squibb generates $49.2B more revenue than Intensity Therapeutics.
Looking for similar companies to Intensity Therapeutics?
Similar Companies
Companies in Shelton with employees in 1-25 range
See 67 companies
Biotechnology companies in ConnecticutSee 125 companies
Biotechnology companies in New York Metropolitan AreaSee 860 companies
Pharmaceuticals & Biotechnology companies in ConnecticutSee 211 companies
Pharmaceuticals & Biotechnology companies in New York Metropolitan AreaSee 1,776 companies
Biotechnology companies with employees in 1-25 rangeSee 3,320 companies
Companies in Connecticut with employees in 1-25 rangeSee 3,392 companies
Pharmaceuticals & Biotechnology companies with employees in 1-25 rangeSee 4,705 companies
Biotechnology companies in USASee 11,823 companies
Trending News for Intensity Therapeutics and Intensity Therapeutics's Competitors
AstraZeneca releases Phase 3 HICKORY trial data for efzimfotase alfa in hypophosphatasia (HPP), showing key secondary improvements.read more...
Amgen stock was at EUR 377.13 pre-market. The Lang & Schwarz quote was recorded at 8:30 a.m. CEST on October 13, 2026. The bid was EUR 375.90 and the a...
Frequently Asked Questions about Intensity Therapeutics
Who are Intensity Therapeutics's top competitors?
Intensity Therapeutics's top 3 competitors are Amgen, AstraZeneca, Bristol-Myers Squibb.Who is similar to Intensity Therapeutics?
Amgen is the most similar to Intensity Therapeutics. AstraZeneca and Bristol-Myers Squibb are also similar to Intensity Therapeutics.
Are Intensity Therapeutics and Amgen competitors?
Yes, Amgen is one of Intensity Therapeutics’s top competitors.